Ixabepilone
Spécifications
219989-84-1Numéro CAS
630-424-7Numéro CE
(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dioneNom IUPAC
C27H42N2O5SFormule chimique
506.7 g/molMasse molaire
Ixabepilone; 219989-84-1; Azaepothilone B; Ixempra; BMS-247550; Ixempra kit; Aza-epothilone B; BMS 247550-01; ixabepilona; NSC-747973; BMS-247550-01; BMS 247550-1; CHEBI:63605; DTXSID70870252; K27005NP0A; 17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione, 7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-((1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)-, (1S,3S,7S,10R,11S,12S,16R)-; 1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-((1E)-1-methyl-2-(2-methylthiazol-4-yl)ethenyl)-17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione; BMS 247550; (1R,5S,6S,7R,10S,14S,16S)-6,10-DIHYDROXY-1,5,7,9,9-PENTAMETHYL-14-((E)-1-(2-METHYL-1,3-THIAZOL-4-YL)PROP-1-EN-2-YL)-17-OXA-13-AZABICYCLO(14.1.0)HEPTADECANE-8,12-DIONE; ixabepilonum; (1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-17-oxa-13-azabicyclo[14.1.0]heptadecane-8,12-dione; 17-Oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione, 7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-, (1S,3S,7S,10R,11S,12S,16R)-; BMS247550; RefChem:56828; Epothilone-B BMS 247550; DTXCID90820734; L01DC04; NSC710428; (1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-((1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)-17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione; (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-((E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl)-17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione; MFCD04307791; (1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-((E)-1-(2-methylthiazol-4-yl)prop-1-en-2-yl)-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione; NSC747973; Ixabepilone [INN]; C27H42N2O5S; (1~{S},3~{S},7~{S},10~{R},11~{S},12~{S},16~{R})-8,8,10,12,16-pentamethyl-3-[(~{E})-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-7,11-bis(oxidanyl)-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione; (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione; Ixempra (TN); Ixabepilone?; FABUFPQFXZVHFB-PVYNADRNSA-N; Ixempra (TM); 16-Aza-epothilone B; Ixabepilone (Standard); IXABEPILONE [MI]; IXABEPILONE [JAN]; IXABEPILONE [HSDB]; IXABEPILONE [USAN]; IXABEPILONE [VANDF]; SCHEMBL8386; IXABEPILONE [MART.]; IXABEPILONE [USP-RS]; IXABEPILONE [WHO-DD]; UNII-K27005NP0A; Ixabepilone (JAN/USAN/INN); Ixabepilone [USAN:INN:JAN]; GTPL6824; orb1225640; orb1300396; CHEMBL1201752; CHEBI:95095; HSDB 7738; IXABEPILONE [ORANGE BOOK]; IXABEPILONE [USP MONOGRAPH]; EX-A1245; BDBM50564768; HY-10222R; AKOS025401600; CCG-269752; CS-0551; DB04845; FD45423; NSC 747973; NSC-710428; NCGC00378665-02; (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-methyl-2-(2-methylthiazol-4-yl)vinyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione; AC-22618; DA-54492; HY-10222; NS00069742; D04645; AB01273979-01; F860594; SR-01000941577; SR-01000941577-1; BRD-K03601870-001-01-2; Q11711607; (1r,5s,6s,7r,10s,14s,16s)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[[e]-1-(2-methyl-1,3-thiazol-4-yl]prop-1-en-2-yl)-17-oxa-13-azabicyclo(14,1,0)heptadecane-8,12-dione; (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-17-Oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione; Azaepothilone B; BMS 247550; BMS; 7-Oxa-4-azabicyclo[14.1.0]heptadecane -5, 7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-, (1S,3S,7S,10R,11S,12S,16R)-; Dihydroxy-1,5,7,9,9-pentamethyl-14-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-17-oxa-13-azabicyclo[14.1.0]hep tadecane-8,12-dione; GZXSynonymes
